FLVCR1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.458400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.546300E-02
Normal-vs-Stage2
3.546800E-01
Normal-vs-Stage3
8.435000E-01
Normal-vs-Stage4
5.708300E-02
Stage1-vs-Stage2
1.022610E-01
Stage1-vs-Stage3
4.151800E-02
Stage1-vs-Stage4
9.181600E-01
Stage2-vs-Stage3
2.261800E-01
Stage2-vs-Stage4
2.188400E-01
Stage3-vs-Stage4
3.733800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.769400E-01
Normal-vs-AfricanAmerican
4.909500E-02
Normal-vs-Asian
4.659000E-01
Caucasian-vs-AfricanAmerican
2.299400E-01
Caucasian-vs-Asian
8.348800E-01
AfricanAmerican-vs-Asian
1.501210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.446600E-01
Normal-vs-Female
5.303000E-01
Male-vs-Female
9.474000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.452400E-02
Normal-vs-Age(41-60Yrs)
2.906200E-01
Normal-vs-Age(61-80Yrs)
5.197800E-01
Normal-vs-Age(81-100Yrs)
4.605200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.990000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.421000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.457800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.398600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.407800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.056400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.819400E-01
Normal-vs-Daily Drinker
8.384400E-01
Normal-vs-Weekly Drinker
3.780000E-01
Normal-vs-Occasional Drinker
7.163700E-02
Normal-vs-Social Drinker
3.309000E-01
Non Drinker-vs-Daily Drinker
4.127700E-02
Non Drinker-vs-Weekly Drinker
8.538400E-01
Non Drinker-vs-Occasional Drinker
2.420800E-01
Non Drinker-vs-Social Drinker
5.801400E-01
Daily Drinker-vs-Weekly Drinker
1.338240E-01
Daily Drinker-vs-Occasional Drinker
8.183600E-02
Daily Drinker-vs-Social Drinker
6.548300E-02
Weekly Drinker-vs-Occasional Drinker
2.206000E-01
Weekly Drinker-vs-Social Drinker
5.295600E-01
Occasional Drinker-vs-Social Drinker
3.734000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.413000E-01
Normal-vs-Grade 2
5.972300E-02
Normal-vs-Grade 3
4.300500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.080000E-01
Grade 1-vs-Grade 3
2.487800E-01
Grade 1-vs-Grade 4
3.413000E-01
Grade 2-vs-Grade 3
7.675800E-01
Grade 2-vs-Grade 4
5.972300E-02
Grade 3-vs-Grade 4
4.300500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.516800E-01
Normal-vs-NonDiabetic
4.610200E-01
Diabetic-vs-NonDiabetic
1.628170E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.743800E-01
Normal-vs-NoPancreatitis
4.877200E-01
Pancreatitis-vs-NoPancreatitis
7.647600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.855400E-03
Normal-vs-N1
3.803200E-01
N0-vs-N1
3.841500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.494200E-01
Normal-vs-TP53-NonMutant
1.480400E-03
TP53-Mutant-vs-TP53-NonMutant
1.021590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
